Proximal renal tubular acidosis: A not so rare disorder of multiple etiologies

Nephrology Dialysis Transplantation

Volumn 27, Issue 12, 2012, Pages 4273-4287

  Haque, Syed K ^a   Ariceta, Gema ^b   Batlle, Daniel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HOSPITAL MATERNO INFANTIL VALL D HEBRON   (Spain)

Author keywords

drug induced pRTA; hereditary pRTA; proximal RTA; renal tubular acidosis

Indexed keywords

ACETAZOLAMIDE; ADEFOVIR; AGMATINE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BEVACIZUMAB; BICARBONATE; BICARBONATE SODIUM COTRANSPORTER; BRINZOLAMIDE; CAPECITABINE; CARBONATE DEHYDRATASE II; CIDOFOVIR; CISPLATIN; CITRATE POTASSIUM; DICLOFENAMIDE; DIDANOSINE; DORZOLAMIDE; GENTAMICIN; HEAVY METAL; HYDROCHLOROTHIAZIDE; IFOSFAMIDE; IRINOTECAN; LOPINAVIR PLUS RITONAVIR; METHAZOLAMIDE; OXALIPLATIN; PROTEINASE INHIBITOR; RITONAVIR; TENOFOVIR; TOPIRAMATE; UNINDEXED DRUG; VALPROIC ACID;

ADENOCARCINOMA; ALTITUDE DISEASE; AUTOSOMAL RECESSIVE INHERITANCE; CA II GENE; CYTOMEGALOVIRUS RETINITIS; DRUG POTENTIATION; DRUG WITHDRAWAL; EPILEPTIC STATE; FANCONI RENOTUBULAR SYNDROME; GENE; GENE MUTATION; GENETIC ASSOCIATION; GLAUCOMA; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOKALEMIA; INTRACRANIAL HYPERTENSION; KIDNEY TUBULE ABSORPTION; KIDNEY TUBULE ACIDOSIS; METABOLIC ACIDOSIS; MIGRAINE; NBCE1 GENE; NEPHROTOXICITY; NONHUMAN; OSTEOSARCOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RARE DISEASE; RENAL REPLACEMENT THERAPY; RESPIRATORY TRACT INFECTION; REVIEW; SEIZURE; SOFT TISSUE SARCOMA; TESTIS CANCER; TREATMENT OUTCOME;

ACIDOSIS, RENAL TUBULAR; ANIMALS; HUMANS; MUTATION;

EID: 84871206767     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs493     Document Type: Review

References (144)

1. Moorthi K, Batlle D. Renal Tubular Acidosis. In: Gennari J, Adrogue HJ, Galla JH, Madias NE (eds). Acid-Base Disorders and Their Treatment. Boca Raton: Taylor and Francis, 2005, pp. 417-459
2. Katzir Z, Dinour D, Reznik-Wolf H, Nissenkorn A, Holtzman E. Familial pure proximal renal tubular acidosis-a clinical and genetic study. Nephrol Dial Transplant 2008; 23: 1211-1215
3. Demirci FY, Chang MH, Mah TS, Romero MF, Gorin MB. Proximal renal tubular acidosis and ocular pathology: a novel missense mutation in the gene (SLC4A4) for sodium bicarbonate cotransporter protein (NBCe1). Mol Vis 2006; 12: 324-330
4. Dinour D, Chang MH, Satoh J et al. A novel missense mutation in the sodium bicarbonate cotransporter (NBCe1/SLC4A4) causes proximal tubular acidosis and glaucoma through ion transport defects. J Biol Chem 2004; 279: 52238-52246
5. Igarashi T, Inatomi J, Sekine T et al. Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet 1999; 23: 264-266
6. Inatomi J, Horita S, Braverman N et al. Mutational and functional analysis of SLC4A4 in a patient with proximal renal tubular acidosis. Pflugers Arch 2004; 448: 438-444
7. Lo YF, Yang SS, Seki G et al. Severe metabolic acidosis causes early lethality in NBC1 W516X knock-in mice as a model of human isolated proximal renal tubular acidosis. Kidney Int 2011; 79: 730-741
8. Alper SL. Familial renal tubular acidosis. J Nephrol 2010; 23: S57-S76
9. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G. Druginduced Fanconi's syndrome. Am J Kidney Dis 2003; 41: 292-309
10. Quigley R. Proximal renal tubular acidosis. J Nephrol 2006; 19: S41-S45
11. Rodriguez Soriano J, Boichis H, Stark H, Edelmann CM, Jr. Proximal renal tubular acidosis. A defect in bicarbonate reabsorption with normal urinary acidification. Pediatr Res 1967; 1: 81-98
12. Rodriguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol 2002; 13: 2160-2170
13. Igarashi T, Sekine T, Inatomi J, Seki G. Unraveling the molecular pathogenesis of isolated proximal renal tubular acidosis. J Am Soc Nephrol 2002; 13: 2171-2177
14. Lemann J, Jr, Adams ND, Wilz DR, Brenes LG. Acid and mineral balances and bone in familial proximal renal tubular acidosis. Kidney Int 2000; 58: 1267-1277
15. Purkerson JM, Schwartz GJ. The role of carbonic anhydrases in renal physiology. Kidney Int 2007; 71: 103-115
16. Batlle D, Haque SK. Genetic causes and mechanisms of distal renal tubular acidosis. Nephrol Dial Transplant 2012; 27: 3691-3704
17. Shapira E, Ben-Yoseph Y, Eyal FG, Russell A. Enzymatically inactive red cell carbonic anhydrase B in a family with renal tubular acidosis. J Clin Invest 1974; 53: 59-63
18. Bolt RJ, Wennink JM, Verbeke JI, Shah GN, Sly WS, Bokenkamp A. Carbonic anhydrase type II deficiency. Am J Kidney Dis 2005; 46: A50, e71-e73
19. Fathallah DM, Bejaoui M, Lepaslier D, Chater K, Sly WS, Dellagi K. Carbonic anhydrase II (CA II) deficiency in Maghrebian patients: evidence for founder effect and genomic recombination at the CA II locus. Hum Genet 1997; 99: 634-637
20. Shah GN, Bonapace G, Hu PY, Strisciuglio P, Sly WS. Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal tubular acidosis and brain calcification): novel mutations in CA2 identified by direct sequencing expand the opportunity for genotype-phenotype correlation. Hum Mutat 2004; 24: 272.
21. Sly WS, Hewett-Emmett D, Whyte MP, Yu YS, Tashian RE. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. Proc Natl Acad Sci USA 1983; 80: 2752-2756
22. Sly WS, Whyte MP, Sundaram V et al. Carbonic anhydrase II deficiency identified as the primary defect in the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N Engl J Med 1985; 313139-145
23. Tasic V, Korneti P, Gucev Z, Hoppe B, Blau N, Cheong HI. Atypical presentation of distal renal tubular acidosis in two siblings. Pediatr Nephrol 2008; 23(7): 1177-81
24. Sirac C, Bridoux F, Essig M, Devuyst O, Touchard G, Cogne M. Toward understanding renal Fanconi syndrome: step by step advances through experimental models. Contrib Nephrol 2011; 169: 247-261
25. Magen D, Berger L, Coady MJ et al. A loss-of-function mutation in NaPi-IIa and renal Fanconi's syndrome. N Engl J Med 2010; 362: 1102-1109
26. Baum M. The Fanconi syndrome of cystinosis: insights into the pathophysiology. Pediatr Nephrol 1998; 12: 492-497
27. Rochman J, Lichtig C, Osterweill D, Tatarsky I, Edelman S. Adult Fanconi's syndrome with renal tubular acidosis in association with renal amyloidosis: occurrence in a patient with chronic lymphocytic leukemia. Arch Intern Med 1980; 140: 1361-1363
28. Messiaen T, Deret S, Mougenot B et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore) 2000; 79: 135-154
29. Riley AL, Ryan LM, Roth DA. Renal proximal tubular dysfunction and paroxysmal nocturnal hemoglobinuria. Am J Med 1977; 62: 125-129
30. Irizarry-Alvarado JM, Dwyer JP, Brumble LM, Alvarez S, Mendez JC. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases. AIDS Read 2009; 19: 114-121
31. Fry AC, Karet FE. Inherited renal acidoses. Physiology (Bethesda) 2007; 22: 202-211
32. Batlle D, Ghanekar H, Jain S, Mitra A. Hereditary distal renal tubular acidosis: new understandings. Annu Rev Med 2001; 52: 471-484
33. Kaunisto K, Parkkila S, Rajaniemi H, Waheed A, Grubb J, Sly WS. Carbonic anhydrase XIV: luminal expression suggests key role in renal acidification. Kidney Int 2002; 61: 2111-2118
34. Soriano JR, Boichis H, Edelmann CM, Jr. Bicarbonate reabsorption and hydrogen ion excretion in children with renal tubular acidosis. J Pediatr 1967; 71: 802-813
35. Edelmann CM, Soriano JR, Boichis H, Gruskin AB, Acosta MI. Renal bicarbonate reabsorption and hydrogen ion excretion in normal infants. J Clin Invest 1967; 46: 1309-1317
36. McSherry E, Sebastian A, Morris RC, Jr. Renal tubular acidosis in infants: the several kinds, including bicarbonate-wasting, classic renal tubular acidosis. J Clin Invest 1972; 51: 499-514
37. Edelman CMJR, Rodriguez-Soriano J, Boichis H. An isolated defect in renal bicarbonate reabsorption as a cause of hyperchloremic acidosis. J Pediatr 1965; 67: 946
38. Batlle DC, Chan YL. Effect of l-arginine on renal tubular bicarbonate reabsorption by the rat kidney. Miner Electr Metab 1989; 15: 187-194
39. Roth KS, Foreman JW, Segal S. The Fanconi syndrome and mechanisms of tubular transport dysfunction. Kidney Int 1981; 20: 705-716
40. Morris RCJ, Sebastian A. Renal tubular acidosis and the Fanconi syndrome. In: Stanbury JB, Wyngaarden JB, Frederickson DS (eds). The Metabolic Basis of Inherited Disease. New York: McGraw-Hill,1983
41. Batlle DC. Renal tubular acidosis. In: Seldin DW, Giebisch G (eds). The Regulation of Acid-Base Balance. New York: Raven Press, 1989, pp. 353-390
42. Laing CM, Toye AM, Capasso G, Unwin RJ. Renal tubular acidosis: developments in our understanding of the molecular basis. Int J Biochem Cell Biol 2005; 37: 1151-1161
43. Borensztein P, Laghmani K, Froissard M, Paillard M. Molecular aspects of Na+/H+ exchange in the renal tubule: localization and adaptation to the acid-base state. Nephrologie 1996; 17: 377-381
44. Zhu Q, Kao L, Azimov R et al. Topological location and structural importance of the NBCe1-A residues mutated in proximal renal tubular acidosis. J Biol Chem 2010; 285: 13416-13426
45. Igarashi T, Inatomi J, Sekine T et al. Novel nonsense mutation in the Na+/HCO3 cotransporter gene (SLC4A4) in a patient with permanent isolated proximal renal tubular acidosis and bilateral glaucoma. J Am Soc Nephrol 2001; 12: 713-718
46. Horita S, Yamada H, Inatomi J et al. Functional analysis of NBC1 mutants associated with proximal renal tubular acidosis and ocular abnormalities. J Am Soc Nephrol 2005; 16: 2270-2278
47. Suzuki M, Vaisbich MH, Yamada H et al. Functional analysis of a novel missense NBC1 mutation and of other mutations causing proximal renal tubular acidosis. Pflugers Arch 2008; 455: 583-593
48. Toye AM, Parker MD, Daly CM et al. The human NBCe1-A mutant R881C, associated with proximal renal tubular acidosis, retains function but is mistargeted in polarized renal epithelia. Am J Physiol Cell Physiol 2006; 291: C788-C801
49. Li HC, Szigligeti P, Worrell RT, Matthews JB, Conforti L, Soleimani M. Missense mutations in Na+:HCO3 ? cotransporter NBC1 show abnormal trafficking in polarized kidney cells: a basis of proximal renal tubular acidosis. Am J Physiol Renal Physiol 2005; 289: F61-F71
50. Aramaki S, Yoshida I, Yoshino M et al. Carbonic anhydrase II deficiency in three unrelated Japanese patients. J Inherit Metab Dis 1993; 16: 982-990
51. Hu PY, Ernst AR, Sly WS, Venta PJ, Skaggs LA, Tashian RE. Carbonic anhydrase II deficiency: single-base deletion in exon 7 is the predominant mutation in Caribbean Hispanic patients. Am J Hum Genet 1994; 54: 602-608
52. Hu PY, Lim EJ, Ciccolella J, Strisciuglio P, Sly WS. Seven novel mutations in carbonic anhydrase II deficiency syndrome identified by SSCP and direct sequencing analysis. Hum Mutat 1997; 9: 383-387
53. Fathallah DM, Bejaoui M, Sly WS, Lakhoua R, Dellagi K. A unique mutation underlying carbonic anhydrase II deficiency syndrome in patients of Arab descent. Hum Genet 1994; 94: 581-582
54. Hu PY, Roth DE, Skaggs LA et al. A splice junction mutation in intron 2 of the carbonic anhydrase II gene of osteopetrosis patients from Arabic countries. Hum Mutat 1992; 1: 288-292
55. Whyte MP, Murphy WA, Fallon MD et al. Osteopetrosis, renal tubular acidosis and basal ganglia calcification in three sisters. Am J Med 1980; 69: 64-74
56. Strisciuglio P, Hu PY, Lim EJ, Ciccolella J, Sly WS. Clinical and molecular heterogeneity in carbonic anhydrase II deficiency and prenatal diagnosis in an Italian family. J Pediatr 1998; 132: 717-720
57. Gawenis LR, Bradford EM, Prasad Vet al. Colonic anion secretory defects and metabolic acidosis in mice lacking the NBC1 Na+/HCO3 cotransporter. J Biol Chem 2007; 282: 9042-9052
58. Nakamura S, Amlal H, Schultheis PJ, Galla JH, Shull GE, Soleimani M. HCO3 reabsorption in renal collecting duct of NHE-3-deficient mouse: a compensatory response. Am J Physiol 1999; 276: F914-F921
59. Barriere H, Belfodil R, Rubera I et al. Role of TASK2 potassium channels regarding volume regulation in primary cultures of mouse proximal tubules. J Gen Physiol 2003; 122: 177-190
60. Warth R, Barriere H, Meneton P et al. Proximal renal tubular acidosis in TASK2 K+ channel-deficient mice reveals a mechanism for stabilizing bicarbonate transport. Proc Natl Acad Sci USA 2004; 101: 8215-8220
61. Nevo N, Chol M, Bailleux A et al. Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nephrol Dial Transplant 25: 1059-1066
62. Pontoglio M, Prie D, Cheret C et al. HNF1alpha controls renal glucose reabsorption in mouse and man. EMBO Rep 2000; 1: 359-365
63. Cheret C, Doyen A, Yaniv M, Pontoglio M. Hepatocyte nuclear factor 1 alpha controls renal expression of the Npt1-Npt4 anionic transporter locus. J Mol Biol 2002; 322: 929-941
64. Lowe CU, Terrey M, Mac LE. Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity. AMA Am J Dis Child 1952; 83: 164-184
65. Attree O, Olivos IM, Okabe I et al. The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5- phosphatase. Nature 1992; 358: 239-242
66. Wrong OM, Norden AG, Feest TG. Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. QJM 1994; 87: 473-493
67. Lloyd SE, Pearce SH, Fisher SE et al. A common molecular basis for three inherited kidney stone diseases. Nature 1996; 379: 445-449
68. Hoopes RR, Jr, Shrimpton AE, Knohl SJ et al. Dent disease with mutations in OCRL1. Am J Hum Genet 2005; 76: 260-267
69. Vilasi A, Cutillas PR, Maher AD et al. Combined proteomic and metabonomic studies in three genetic forms of the renal Fanconi syndrome. Am J Physiol Renal Physiol 2007; 293: F456-F467
70. Manz F, Bickel H, Brodehl J et al. Fanconi-Bickel syndrome. Pediatr Nephrol 1987; 1: 509-518
71. Karlmark B, Agerup B, Wistrand PJ. Renal proximal tubular acidification. Role of brush-border and cytoplasmic carbonic anhydrase. Acta Physiol Scand 1979; 106: 145-150
72. Schwartz GJ. Physiology and molecular biology of renal carbonic anhydrase. J Nephrol 2002; 15: S61-S74
73. Winum JY, Poulsen SA, Supuran CT. Therapeutic applications of glycosidic carbonic anhydrase inhibitors. Med Res Rev 2009; 29: 419-435
74. Supuran CT, Scozzafava A. Benzolamide is not a membrane-impermeant carbonic anhydrase inhibitor. J Enzyme Inhib Med Chem 2004; 19: 269-273
75. Keilani T, Segal R, Esparaz D, Winchell G, Tanaka W, Connor J, Lippa E, Levine B, Batlle D. Effect of Dorzolamide, a novel topical carbonic anhydrase inhibitor, on urinary acidification in subjects with moderate renal impairment (clinical research meeting). J Investig Med 1995
76. Voute PA, van den Berg H, Behrendt H, Michiels E, de Kraker J. Ifosfamide in the treatment of pediatric malignancies. Semin Oncol 1996; 23: 8-11
77. Bokemeyer C, Harstrick A, Beyer J et al. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group. Semin Oncol 1998; 25: 24-32; discussion 45-8
78. Rossi R, Pleyer J, Schafers P et al. Development of ifosfamideinduced nephrotoxicity: prospective follow-up in 75 patients. Med Pediatr Oncol 1999; 32: 177-182
79. Loebstein R, Atanackovic G, Bishai R et al. Risk factors for longterm outcome of ifosfamide-induced nephrotoxicity in children. J Clin Pharmacol 1999; 39: 454-461
80. Oberlin O, Fawaz O, Rey A et al. Long-term evaluation of Ifosfamide-related nephrotoxicity in children. J Clin Oncol 2009; 27: 5350-5355
81. Stohr W, Paulides M, Bielack S et al. Ifosfamide-induced nephrotoxicity in 593 sarcoma patients: a report from the Late Effects Surveillance System. Pediatr Blood Cancer 2007; 48: 447-452
82. Negro A, Regolisti G, Perazzoli F, Davoli S, Sani C, Rossi E. Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient. Nephrol Dial Transplant 1998; 13: 1547-1549
83. Beckwith C, Flaharty KK, Cheung AK, Beatty PG. Fanconi's syndrome due to ifosfamide. Bone Marrow Transplant 1993; 11: 71-73
84. Farry JK, Flombaum CD, Latcha S. Long term renal toxicity of ifosfamide in adult patients-5 year data. Eur J Cancer 2012; 48: 1326-1331
85. Kollataj B, Zajaczkowska M, Katski K et al. [Acquired Fanconi-de Toni-Debre syndrome due to therapy for Ewing's sarcoma in 5-years old boy]. Przegl Lek 2006; 63: 220-222
86. Rogowska E, Wozniak W. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome]. Med Wieku Rozwoj 2004; 8: 289-295
87. Nissim I, Horyn O, Daikhin Y, Luhovyy B, Phillips PC, Yudkoff M. Ifosfamide-induced nephrotoxicity: mechanism and prevention. Cancer Res 2006; 66: 7824-7831
88. Yaseen Z, Michoudet C, Baverel G, Dubourg L. Mechanisms of the ifosfamide-induced inhibition of endocytosis in the rat proximal kidney tubule. Arch Toxicol 2008; 82: 607-614
89. Linch M, Cunningham D, Mingo O, Stiles A, Farquhar-Smith WP. Renal tubular acidosis due to oxaliplatin. Ann Oncol 2007; 18: 805-806
90. Negro A, Grasselli C, Galli P. Oxaliplatin-induced proximal renal tubular acidosis. Intern Emerg Med 2010; 5: 267-268
91. Cachat F, Nenadov-Beck M, Guignard JP. Occurrence of an acute Fanconi syndrome following cisplatin chemotherapy. Med Pediatr Oncol Suppl 1998; 31: 40-41
92. Portilla D, Li S, Nagothu KK et al. Metabolomic study of cisplatin-induced nephrotoxicity. Kidney Int 2006; 69: 2194-2204
93. Nagothu KK, Bhatt R, Kaushal GP, Portilla D. Fibrate prevents cisplatin-induced proximal tubule cell death. Kidney Int 2005; 68: 2680-2693
94. Xu EY, Perlina A, Vu H et al. Integrated pathway analysis of rat urine metabolic profiles and kidney transcriptomic profiles to elucidate the systems toxicology of model nephrotoxicants. Chem Res Toxicol 2008; 21: 1548-1561
95. Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther 2010; 128: 119-128
96. Earle KE, Seneviratne T, Shaker J, Shoback D. Fanconi's syndrome in HIV+ adults: report of three cases and literature review. J Bone Miner Res 2004; 19: 714-721
97. Nelson M, Azwa A, Sokwala A, Harania RS, Stebbing J. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy. AIDS 2008; 22: 1374-1376
98. Gupta SK. Tenofovir-associated Fanconi syndrome: review of the FDA adverse event reporting system. AIDS Patient Care STDS 2008; 22: 99-103
99. Kearney BP, Mathias A, Mittan A, Sayre J, Ebrahimi R, Cheng AK. Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavir. J Acquir Immune Defic Syndr 2006; 43: 278-283
100. Gupta SK, Eustace JA, Winston JA et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2005; 40: 1559-1585
101. Hall AM, Hendry BM, Nitsch D, Connolly JO. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence. Am J Kidney Dis 2011; 57: 773-780
102. Imaoka T, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y. Functional involvement of multidrug resistanceassociated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol 2007; 71: 619-627
103. Rodriguez-Novoa S, Labarga P, Soriano V et al. Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study. Clin Infect Dis 2009; 48: e108-e116
104. D'Ythurbide G, Goujard C, Mechai F, Blanc A, Charpentier B, Snanoudj R. Fanconi syndrome and nephrogenic diabetes insipidus associated with didanosine therapy in HIV infection: a case report and literature review. Nephrol Dial Transplant 2007; 22: 3656-3659
105. Crowther MA, Callaghan W, Hodsman AB, Mackie ID. Dideoxyinosine- associated nephrotoxicity. AIDS 1993; 7: 131-132
106. Izzedine H, Launay-Vacher V, Deray G. Fanconi syndrome associated with didanosine therapy. AIDS 2005; 19: 844-845
107. Mirza N, Marson AG, Pirmohamed M. Effect of topiramate on acid-base balance: extent, mechanism and effects. Br J Clin Pharmacol 2009; 68: 655-661
108. Ozer Y, Altunkaya H. Topiramate induced metabolic acidosis. Anaesthesia 2004; 59: 830.
109. Philippi H, Boor R, Reitter B. Topiramate and metabolic acidosis in infants and toddlers. Epilepsia 2002; 43: 744-747
110. Sacre A, Jouret F, Manicourt D, Devuyst O. Topiramate induces type 3 renal tubular acidosis by inhibiting renal carbonic anhydrase. Nephrol Dial Transplant 2006; 21: 2995-2996
111. Recacha R, Costanzo MJ, Maryanoff BE, Chattopadhyay D. Crystal structure of human carbonic anhydrase II complexed with an anti-convulsant sugar sulphamate. Biochem J 2002; 361: 437-441
112. Maryanoff BE, McComsey DF, Costanzo MJ, Hochman C, Smith-Swintosky V, Shank RP. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform. J Med Chem 2005; 48: 1941-1947
113. Knorr M, Schaper J, Harjes M, Mayatepek E, Rosenbaum T. Fanconi syndrome caused by antiepileptic therapy with valproic acid. Epilepsia 2004; 45: 868-871
114. Endo A, Fujita Y, Fuchigami T, Takahashi S, Mugishima H. Fanconi syndrome caused by valproic acid. Pediatr Neurol 42: 287-290
115. Hawkins E, Brewer E. Renal toxicity induced by valproic acid (Depakene). Pediatr Pathol 1993; 13: 863-868
116. Lenoir GR, Perignon JL, Gubler MC, Broyer M. Valproic acid: a possible cause of proximal tubular renal syndrome. J Pediatr 1981; 98: 503-504
117. Ghiculescu RA, Kubler PA. Aminoglycoside-associated Fanconi syndrome. Am J Kidney Dis 2006; 48: e89-e93
118. Gainza FJ, Minguela JI, Lampreabe I. Aminoglycoside-associated Fanconi's syndrome: an underrecognized entity. Nephron 1997; 77: 205-211
119. Melnick JZ, Baum M, Thompson JR. Aminoglycoside-induced Fanconi's syndrome. Am J Kidney Dis 1994; 23: 118-122
120. Lenz EM, Bright J, Knight R et al. Metabonomics with 1H-NMR spectroscopy and liquid chromatography-mass spectrometry applied to the investigation of metabolic changes caused by gentamicin-induced nephrotoxicity in the rat. Biomarkers 2005; 10: 173-187
121. Fleck C, Schwertfeger M, Taylor PM. Regulation of renal amino acid (AA) transport by hormones, drugs and xenobiotics-a review. Amino Acids 2003; 24: 347-374
122. Vittecoq D, Dumitrescu L, Beaufils H, Deray G. Fanconi syndrome associated with cidofovir therapy. Antimicrob Agents Chemother 1997; 41: 1846
123. Shaikh A, Wiisanen ME, Gunderson HD, Leung N. Acquired Fanconi syndrome after treatment with capecitabine, irinotecan, and bevacizumab. Ann Pharmacother 2009; 43: 1370-1373
124. Batlle D, Hays S, Foley R, Chan Y, Arruda JA, Kurtzman NA. Proximal renal tubular acidosis and hypophosphatemia induced by arginine. Adv Exp Med Biol 1982; 151: 239-249
125. Garcia Rodriguez JF, Sanchez-Guisande D, Novoa D, Romero R, Arcocha V. Fanconi syndrome caused by mercury chloride poisoning. Rev Clin Esp 1989; 184: 111-112
126. Johri N, Jacquillet G, Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. Biometals 2010; 23: 783-792
127. Taylor HC, Elbadawy EH. Renal tubular acidosis type 2 with Fanconi's syndrome, osteomalacia, osteoporosis, and secondary hyperaldosteronism in an adult consequent to vitamin D and calcium deficiency: effect of vitamin D and calcium citrate therapy. Endocr Pract 2006; 12: 559-567
128. Guignard JP, Torrado A. Proximal renal tubular acidosis in vitamin D deficiency rickets. Acta Paediatr Scand 1973; 62: 543-546
129. Vainsel M, Manderlier T, Vis HL. Proximal renal tubular acidosis in vitamin D deficiency rickets. Biomedicine 1975; 22: 35-40
130. Maldonado JE, Velosa JA, Kyle RA, Wagoner RD, Holley KE, Salassa RM. Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med 1975; 58: 354-364
131. Bridoux F, Sirac C, Hugue Vet al. Fanconi's syndrome induced by a monoclonal Vkappa3 light chain in Waldenstrom's macroglobulinemia. Am J Kidney Dis 2005; 45: 749-757
132. Rikitake O, Sakemi T, Yoshikawa Y, Nagano Y, Watanabe T. Adult Fanconi syndrome in primary amyloidosis with lambda light-chain proteinuria. Jpn J Med 1989; 28: 523-526
133. Batlle DC, Mozes MF, Manaligod J, Arruda JA, Kurtzman NA. The pathogenesis of hyperchloremic metabolic acidosis associated with kidney transplantation. Am J Med 1981; 70: 786-796
134. Friedman A, Chesney R. Fanconi's syndrome in renal transplantation. Am J Nephrol 1981; 1: 45-47
135. Hsiao PJ, Wang SC, Wen MC, Diang LK, Lin SH. Fanconi syndrome and CKD in a patient with paroxysmal nocturnal hemoglobinuria and hemosiderosis. Am J Kidney Dis 55: e1-e5
136. Brenner RJ, Spring DB, Sebastian A et al. Incidence of radiographically evident bone disease, nephrocalcinosis, and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med 1982; 307: 217-221
137. Batlle D, Moorthi KM, Schlueter W, Kurtzman N. Distal renal tubular acidosis and the potassium enigma. Semin Nephrol 2006; 26: 471-478
138. Batlle DC, Hizon M, Cohen E, Gutterman C, Gupta R. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med 1988; 318: 594-599
139. Brenes LG, Brenes JN, Hernandez MM. Familial proximal renal tubular acidosis. A distinct clinical entity. Am J Med 1977; 63: 244-252
140. Nash MA, Torrado AD, Greifer I, Spitzer A, Edelmann CM, Jr. Renal tubular acidosis in infants and children. Clinical course, response to treatment, and prognosis. J Pediatr 1972; 80: 738-748
141. Brenes LG, Sanchez MI. Impaired urinary ammonium excretion in patients with isolated proximal renal tubular acidosis. J Am Soc Nephrol 1993; 4: 1073-1078
142. McSherry E, Morris RC, Jr. Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 1978; 61: 509-527
143. Rampini S, Fanconi A, Illig R, Prader A. Effect of hydrochlorothiazide on proximal renal tubular acidosis in a patient with idiopathic 'de toni-debre-fanconi syndrome'. Helv Paediatr Acta 1968; 23: 13-21
144. Rodriguez-Soriano J, Edelmann CM, Jr. Renal tubular acidosis. Annu Rev Med 1969; 20: 363-382